Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
about
Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical dataTumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy.Dosimetry for radiopharmaceutical therapyMonte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETUse of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparisonStudy of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.Regularized reconstruction in quantitative SPECT using CT side information from hybrid imaging.Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy.Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetryDevelopment and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy.Technological development and advances in single-photon emission computed tomography/computed tomography.Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4.Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.Tumor dosimetry and response for 153Sm-ethylenediamine tetramethylene phosphonic acid therapy of high-risk osteosarcoma.Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.Improving external beam radiotherapy by combination with internal irradiationStrengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Three-dimensional imaging-based radiobiological dosimetry.Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.Radioiodine for remnant ablation and therapy of metastatic disease.Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images.Patient dosimetry in nuclear medicine.Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters.A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.Calculation of the biological effective dose for piecewise defined dose-rate fitsA model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.JADA: a graphical user interface for comprehensive internal dose assessment in nuclear medicine.PATIENT-SPECIFIC DOSIMETRY FOR PEDIATRIC IMAGING OF 99mTc-DIMERCAPTOSUCCINIC ACID WITH GATE MONTE CARLO CODE.Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.SPECT/CT in the Treatment of Differentiated Thyroid Cancer.Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer.Dosimetry for nonuniform activity distributions: a method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations.An innovative iterative thresholding algorithm for tumour segmentation and volumetric quantification on SPECT images: Monte Carlo-based methodology and validation.
P2860
Q30977013-C34D57B8-5928-4FEE-8662-743BCCE300A3Q33427043-9BE86FD6-8253-42B2-B8C9-FF06E4AE743AQ33665116-BEA14AD0-0F30-45A2-8087-582725CE4DFBQ33682852-9672E914-CE6C-4617-8271-14156E1DD857Q33740436-AAADA6B6-3955-4D8C-8FFE-25A7CD519968Q33749165-C174814D-C4CC-4399-937D-C05283AB6ECCQ33768719-19AE07AB-FA07-459B-86F3-46AC9BB8688CQ33930006-02AF15C0-53CB-44B4-A463-7CB4D7DCBBE8Q34255798-B22965A1-3074-4363-891C-1C6F110C4A5EQ34282486-799C22FE-005F-4F7F-AF69-BA72C2504D3AQ34563194-37765CDE-84CC-45FD-A095-188DB0F637BAQ34626322-B67112E0-9214-478B-9010-AA14FDE80AACQ34663152-66ABA0FF-A21E-4106-B0E7-3858089BEC85Q35067264-FFB08C1C-4B4D-4610-9DD1-AF1200B14864Q35187944-FBA2FD1F-1EC7-40E2-A123-E60174757B63Q35792772-E9711C30-B86B-4FC1-B83F-81C9B974AFA4Q35851824-93D195F8-67F6-4F95-B4C8-CC04658E73C6Q36235732-2F6993D4-417E-40EE-B090-11950EE85430Q36297804-938F4054-2FAB-4969-8D4C-49F03CFB9F65Q36300599-A727794D-FD9F-4500-B8B3-16AF689F4DE6Q36899620-7D3B0E88-B32C-4718-A47D-16B5AFF90AFBQ37002485-61181716-C06F-441F-ACDB-C9C815932D1EQ37864164-86FEE451-4A09-45D0-89BD-D26DD0C954DEQ37913996-96A6C835-25D2-45C0-8343-08EDA18373E3Q39637887-461077D2-DD6B-4001-83D2-F935143D4383Q40036028-ECC91F26-BDE7-4A0D-AB8B-8A9BD075EAEAQ41142775-70F21D43-622A-4B83-BD62-CCDCD4A2FE51Q42038270-10269F24-C104-4D40-9814-05913D82713EQ42093398-38F1469C-FA8B-428A-B382-E40D5CD9A711Q42122579-63298FC7-BB95-463B-8342-075665D9A0FFQ42543642-68B730F7-0310-4C85-A8CF-D1CF387C0F5DQ42763210-F196C059-9AF8-49E7-BFF4-AB49BC33F092Q45792248-E92341E4-ECB3-485D-9906-3AD5EE09AAA9Q49579176-3446D4C6-D102-47A2-8164-EC6D5A3BDB72Q49827187-C4894196-9778-44B2-97A6-E79585D572B3Q49834504-D77D8A16-2183-4AB0-B44F-223BD0FD0836Q50133955-611C1881-A7B6-4994-A206-3BEFE8D5CB70Q51235781-DB413B9A-0B0D-4897-B470-9B35400C0A14Q51542387-67E3B92B-5F38-4E42-BBCB-143328D6A692
P2860
Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@en
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@nl
type
label
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@en
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@nl
prefLabel
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@en
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@nl
P2093
P2860
P1476
Three-dimensional radiobiologi ...... ging-based internal dosimetry.
@en
P2093
Andrew R Prideaux
Eric C Frey
Paul W Ladenson
Richard L Wahl
P2860
P304
P356
10.2967/JNUMED.106.038000
P407
P577
2007-05-15T00:00:00Z